Am I the only one who notices that
Endeavour Rx is targeted at
8-12 years olds
and TALi is targeted at
3-8 year olds
Ask any clinician and they will say each age group has its own needs i.e. Endevavour and TALi are not competing for the same market share.
Glen should be jumping on the coat tails of endeavour RX news swell and promoting the cr*p out of TALi as home grown variant.
Hope there is significant revenue in the upcoming qtr
Tali Health 2020, page-1551
-
- There are more pages in this discussion • 740 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TD1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.295M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 24843912 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 26527964 | 12 |
View Market Depth
| Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
| TD1 (ASX) Chart |
Day chart unavailable